share_log

4: Statement of changes in beneficial ownership of securities-Director Fry Simon Jeremy

4: Statement of changes in beneficial ownership of securities-Director Fry Simon Jeremy

4：持股变动声明-董事 Fry Simon Jeremy
美股SEC公告 ·  2024/12/21 06:10

Moomoo AI 已提取核心信息

Conduit Pharmaceuticals has reported a future transaction involving Fry Simon Jeremy, scheduled for 12/18/2024. The announcement provides limited details about the nature and scope of the transaction.Fry Simon Jeremy, whose relationship to the issuer is not specified, is listed as the reporting person with an address in Naples, FL. The lack of information in the Table 1 Non-Derivative Securities section suggests this may not involve a straightforward stock purchase or sale.Investors should note that this is a forward-looking announcement, with the transaction date set nearly a year in the future. Further details or amendments may be forthcoming as the date approaches.
Conduit Pharmaceuticals has reported a future transaction involving Fry Simon Jeremy, scheduled for 12/18/2024. The announcement provides limited details about the nature and scope of the transaction.Fry Simon Jeremy, whose relationship to the issuer is not specified, is listed as the reporting person with an address in Naples, FL. The lack of information in the Table 1 Non-Derivative Securities section suggests this may not involve a straightforward stock purchase or sale.Investors should note that this is a forward-looking announcement, with the transaction date set nearly a year in the future. Further details or amendments may be forthcoming as the date approaches.
Conduit Pharmaceuticals报告了一项未来交易，涉及Fry Simon Jeremy，计划于2024年12月18日进行。公告提供了关于交易性质和范围的有限细节。Fry Simon Jeremy与发行人的关系未说明，被列为报告人，地址位于佛罗里达州那不勒斯。表1非衍生证券部分缺乏信息，表明这可能不是一个简单的股票买卖。投资者应注意，这是一项前瞻性公告，交易日期设定在未来近一年。随着日期的临近，可能会有进一步的细节或修正。
Conduit Pharmaceuticals报告了一项未来交易，涉及Fry Simon Jeremy，计划于2024年12月18日进行。公告提供了关于交易性质和范围的有限细节。Fry Simon Jeremy与发行人的关系未说明，被列为报告人，地址位于佛罗里达州那不勒斯。表1非衍生证券部分缺乏信息，表明这可能不是一个简单的股票买卖。投资者应注意，这是一项前瞻性公告，交易日期设定在未来近一年。随着日期的临近，可能会有进一步的细节或修正。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Corcept医疗
    CORT
    -- 114.220
    ABVC BioPharma
    ABVC
    -- 1.0600
    bluebird bio
    BLUE
    -- 4.880
    NLS Pharmaceutics
    NLSP
    -- 1.5400
    DBV Technologies
    DBVT
    -- 6.820
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    FOMC维持利率但不确定性高企：美股后市走向如何？
    🎙️讨论 1. 美联储强调政策路径存在“高度不确定性”，你更关注利率预期变化还是经济数据对市场的短期影响？ 2. 若核心通胀维持高位，哪类板块更具交易机会——防御型股票还是科技成长股？ 展开
    联邦公开市场委员会新闻发布会，2025年3月19日